BODE Index for COPD Survival

The BODE Index is a multidimensional score that predicts COPD mortality using body mass index, airflow obstruction, dyspnea, and exercise capacity.

FEV1 (% of predicted)
≥ 65%050-64%+136-49%+2≤ 35%+3
6 Minute Walk Distance
≥ 350 m (383 yds)0250-349 m (273-382 yds)+1150-249 m (164-272 yds)+2≤149 m (163 yds)+3
mMRC Dyspnea Scale
Dyspnea only with strenuous exercise0Dyspnea when hurrying or walking up a slight hill: 0 pts Walks slower than people of same age because of dyspnea or stops for breath when walking at own pace0Walks slower than people of same age because of dyspnea or stops for breath when walking at own pace+1Stops for breath after walking 100 yards (91 m) or after a few minutes+2Too dyspneic to leave house or breathless when dressing+3
BMI (kg/m2)
> 210≤ 21+1

Indications for Use

Estimate survival in symptomatic, stable COPD to guide prognosis, transplant referral, and intensity of follow‑up. It applies to ambulatory patients with confirmed airflow obstruction and integrates BMI, FEV1, dyspnea, and 6‑minute walk distance. It provides stronger mortality discrimination than FEV1 alone (C‑statistic 0.74 vs 0.65 in a 625‑patient validation cohort 1 [Level I evidence]). Also useful for tracking progression and response to interventions (e.g., pulmonary rehabilitation).

Insights & Cautions

Higher scores indicate higher mortality risk, with each 1‑point increase raising death risk by 34% 1 [Level I evidence]. Validated across cohorts and superior to FEV1 alone.

  • May underperform when comorbidities dominate; adding COTE improves prediction 2 [Level II evidence].
  • Requires accurate 6‑minute walk testing; performance varies with demographic and disease heterogeneity.